The European Patent Office published patent application EP3937847A1 for a tissue repair scaffold and device developed by the University of Manchester. The patent covers prosthetics technology in the A61F classification with related biomaterials in A61L. Protection is designated for all European Patent Convention contracting states including DE, FR, GB, IT, ES, and others.\n\nPatent applicants and medical device manufacturers should review the published claims to assess potential infringement risks or licensing opportunities. Research institutions developing similar tissue engineering technologies may need to conduct freedom-to-operate analyses. The publication date of March 25, 2026 marks the beginning of the opposition period during which third parties may file observations.